Medical News

RSS

2010 International Conference on Emerging Infectious Diseases at Atlanta, Georgia

Journalists are invited to attend and cover the 2010 International Conference on Emerging Infectious Diseases (ICEID), to be held July 11-14, 2010, at the Hyatt Regency, Atlanta, Georgia. The meeting is being organized by the Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories and the World Health Organization.

10 Jun 2010

Men with MS may require education, support to manage their disease and therapy: Research

New research co-published by Saint Louis University and Express Scripts, Inc., suggests that men with multiple sclerosis may require more education and support to manage their disease and therapy than women with MS. Men also may benefit from more targeted adherence interventions.

10 Jun 2010

Curexo Technology's ROBODOC assists in first commercial hip replacement surgery

Curexo Technology Corporation made history on Wednesday, May 26, 2010 when its next-generation ROBODOC® Surgical System assisted Dr. William Bargar as he performed the first commercial hip replacement surgery on Warren Roberts of Davis, CA. Mr. Roberts had his left hip replacement using this robotic device in 1995 as a part of an FDA study. This recent surgery performed at Sutter General in Sacramento was for Mr. Roberts' right hip.

10 Jun 2010

New information to help patients make important decision regarding stem cell treatments

Patients hoping to learn more about the credibility of clinics selling stem cell treatments abroad will soon have new information to help them make important and often costly decisions regarding their health. A report released today by the Task Force on Unproven Stem Cell Treatments, convened by the International Society for Stem Cell Research outlines criteria by which people can evaluate the claims made by the hundreds of so-called "rogue" clinics operating across the globe.

10 Jun 2010

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

BioImagene, the leading provider of innovative digital pathology solutions, today announced that they have signed an agreement to equip Dartmouth-Hitchcock Medical Center (DHMC) with their complete suite of digital pathology solutions. DHMC will use iScan Coreo Au™ slide scanner and Virtuoso™ digital pathology application software to streamline laboratory workflow and enhance the Pathology Department's educational and residency programs.

10 Jun 2010

Veracyte announces completion of Series B round

Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.

10 Jun 2010

Scientists discover how polyphenols present in red wine and green tea inhibit prostate cancer growth

In what could lead to a major advance in the treatment of prostate cancer, scientists now know exactly why polyphenols in red wine and green tea inhibit cancer growth. This new discovery, published online in The FASEB Journal, explains how antioxidants in red wine and green tea produce a combined effect to disrupt an important cell signaling pathway necessary for prostate cancer growth.

10 Jun 2010

Increased use of intrauterine devices reduces unwanted pregnancies

A study from the University of Gothenburg, Sweden, which monitored a group of women for 25 years showed that the combined oral contraceptive pill (the pill) is the most common form of contraceptive among women under 29. At the same time many young women have unwanted pregnancies resulting in repeated abortions. According to the researchers increased use of an intrauterine device at a younger age would reduce the number of unwanted pregnancies.

10 Jun 2010

Argus Optical Mapping System for microbial whole genome analysis launched at ASM 2010 General Meeting

OpGen, Inc., a microbial genomics solutions company, announced the launch of the Argus Optical Mapping System for microbial whole genome analysis at the ASM 2010 General Meeting held in San Diego, CA May 23-27, 2010. The Argus Optical Mapping System is based on Optical Mapping Technology which generates ordered, whole genome restriction maps from single DNA molecules.

10 Jun 2010

NICE decides not to recommend lapatinib for women with advanced breast cancer

The National Institute for Health and Clinical Excellence has decided not to recommend the oral drug lapatinib (Tyverb) for women with advanced breast cancer, except for use in clinical trials.

10 Jun 2010

World Bank, partner programs 'not achieving intended outcomes' for TB in Africa, report says

A report, released Wednesday by the group ACTION (Advocacy to Control TB Internationally), finds that the World Bank and its partners' programs to fight tuberculosis in sub-Saharan Africa are "not achieving intended outcomes" and have been mostly ineffective, Agence France-Presse reports.

10 Jun 2010

Drinking coffee may help prevent diabetes, report scientists

Scientists are reporting new evidence that drinking coffee may help prevent diabetes and that caffeine may be the ingredient largely responsible for this effect. Their findings, among the first animal studies to demonstrate this apparent link, appear in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

10 Jun 2010

Bayer receives silver Medical Design Excellence Award for CONTOUR USB blood glucose meter

Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.

10 Jun 2010

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.

10 Jun 2010

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Roxane Laboratories, Inc. announced today the Abbreviated New Drug Application (ANDA) approval of Valacyclovir Hydrochloride Tablets 500mg and

10 Jun 2010

Combination therapy appears to improve outcome of women with late-stage ovarian cancer

The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.

10 Jun 2010

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.

10 Jun 2010

GE Healthcare presents interim phase 2 study results of fluciclatide

GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.

10 Jun 2010

ADF Solutions awarded key patent for digital forensics

ADF Solutions, Inc., the leading provider of forensic triage tools for computers and peripherals, is pleased to announce that it has been granted a patent by the U.S. Patent and Trademark Office pertaining to methods of searching forensic data. The patent has critical applications for forensic triage, cyber-security, cyber-intelligence, digital forensics, and e-discovery.

10 Jun 2010

Microscopic polymer fibers for rebuilding human tissue, speeding healing process

Queen's University Brian Amsden is hoping that in about 10 years a tendon, spinal cord or heart valve will be able to regenerate itself after an injury or disease. The chemical engineering professor, along with scientists from the University of Western Ontario and University of Toronto, is currently trying to develop microscopic polymer fibers to help rebuild human tissue and speed the healing process.

10 Jun 2010

Medical News

2010 International Conference on Emerging Infectious Diseases at Atlanta, Georgia

Men with MS may require education, support to manage their disease and therapy: Research

Curexo Technology's ROBODOC assists in first commercial hip replacement surgery

New information to help patients make important decision regarding stem cell treatments

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

Veracyte announces completion of Series B round

Scientists discover how polyphenols present in red wine and green tea inhibit prostate cancer growth

Increased use of intrauterine devices reduces unwanted pregnancies

Argus Optical Mapping System for microbial whole genome analysis launched at ASM 2010 General Meeting

NICE decides not to recommend lapatinib for women with advanced breast cancer

World Bank, partner programs 'not achieving intended outcomes' for TB in Africa, report says

Drinking coffee may help prevent diabetes, report scientists

Bayer receives silver Medical Design Excellence Award for CONTOUR USB blood glucose meter

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Combination therapy appears to improve outcome of women with late-stage ovarian cancer

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

GE Healthcare presents interim phase 2 study results of fluciclatide

ADF Solutions awarded key patent for digital forensics

Microscopic polymer fibers for rebuilding human tissue, speeding healing process

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News